NEWBRY — Newbury Pharmaceuticals AB Cashflow Statement
0.000.00%
Last trade - 00:00
- SEK63.83m
- SEK57.42m
- SEK10.27m
2021 August 31st | 2022 August 31st | 2023 August 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS |
Status: | Final | Final | Final |
Net Income/Starting Line | -5.56 | -14.7 | -19.4 |
Non-Cash Items | 0.608 | 1.03 | 1.57 |
Other Non-Cash Items | |||
Changes in Working Capital | 0.883 | -1.36 | -5.37 |
Change in Accounts Receivable | |||
Change in Inventories | |||
Change in Accounts Payable | |||
Change in Other Liabilities | |||
Net Change in Other Assets & Liabilities | |||
Cash from Operating Activities | -4.07 | -15 | -23.2 |
Capital Expenditures | -23.1 | -24.4 | -0.862 |
Purchase / Acquisition of Intangibles | |||
Other Investing Cash Flow Items | -3.65 | 0 | 0 |
Change in Net Investments | |||
Cash from Investing Activities | -26.7 | -24.4 | -0.862 |
Net Issuance / Retirement of Stock | |||
Net Issuance / Retirement of Debt | |||
Cash from Financing Activities | 43.9 | 59.6 | -0.717 |
Beginning Cash Balance | |||
Ending Cash Balance | |||
Net Change in Cash | 13.1 | 20.2 | -24.8 |